SCHEMBL823263

SCHEMBL823263

CC(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)c1ccc(C(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.59
ELANE P08246 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
KMT2A Q03164 3/20 0.51
PPARG P37231 2/20 0.51
PPARA Q07869 2/20 0.51
MAPK1 P28482 2/20 0.51
CNR1 P21554 2/20 0.51
LMNA P02545 2/20 0.51
MEN1 O00255 2/20 0.51
MAPT P10636 2/20 0.51
USP2 O75604 1/20 0.51
ABCB11 O95342 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
CYP2C9 P11712 1/20 0.51
ADRB3 P13945 1/20 0.51
TSHR P16473 1/20 0.51
ACHE P22303 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7868865 0.84 L3MBTL1 (0.47) SMN1; SMN2KMT2APPARGPPARALMNA
SCHEMBL27912406 0.84 HPGD (0.65) HPGDELANESMN1; SMN2KMT2APPARG
SCHEMBL11856069 0.83 SRD5A2 (0.54) ELANEKMT2ASRD5A2LTB4RLTB4R2
SCHEMBL10227055 0.83 PPARG (0.44) HPGDELANESMN1; SMN2KMT2APPARG
SCHEMBL7871757 0.81 POLB (0.43) HPGDSMN1; SMN2KMT2AMEN1MAPT
SCHEMBL7871754 0.81 POLB (0.43) HPGDSMN1; SMN2KMT2AMEN1MAPT
SCHEMBL8638497 0.80 HPGD (0.59) HPGDELANESMN1; SMN2KMT2APPARG
SCHEMBL8638490 0.80 HPGD (0.59) HPGDELANESMN1; SMN2KMT2APPARG
SCHEMBL3151943 0.80 CNR1 (0.60) HPGDELANESMN1; SMN2KMT2APPARG
SCHEMBL21991482 0.78 HPGD (0.60) HPGDELANESMN1; SMN2KMT2APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1995265-B1 POLYARYLENE AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL CO (JP) 2012-08-01 EP disclosed
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275859-A1 METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND C9, H1-10, CYP1A1 HPGD 3914/4885ELANE 3004/4885SMN1; SMN2 2997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.